Europeans back in the game as Deka closes in on Brisbane tower
The Abu Dhabi Investment Authority and Lendlease's APPF Commercial fund will both sell their stakes in 66 Eagle Street.

Europeans back in the game as Deka closes in on Brisbane tower

German group Deka Immobilien is leading the race for one of Brisbane’s landmark buildings following strong competition for the 30-floor office tower.

The fund manager is currently undertaking due diligence on the A-grade office building known as Central Plaza 2, which is expected to sell for more than $370 million. Abacus, GPT, Charter Hall and GIC had previously been in the running for the asset, market sources told The Australian Financial Review.

JLL and Cushman & Wakefield are running the sales campaign but declined to comment.

Deka’s pursuit of the Brisbane asset is the latest indication European investors are edging back into Australia’s commercial property market after a period of lacklustre activity.

Europe’s record low interest rates, relative to Australia’s at the time, had caused hedging costs to rise and encouraged institutional investors to deploy capital in other markets.

Fund managers and selling agents say Australia’s new low interest rate environment and higher yield environment relative to Europe is making the market a more attractive proposition.

Other European investors have also re-emerged in the local market in the past year.

In September, the real estate arm of Zurich-based investment bank Credit Suisse emerged as the buyer of the Jubilee Place office development in Brisbane’s Fortitude Valley in a $180 million forward-funding deal.

Late last year, Deka bought the Sydney CBD property that houses Bulgari’s flagship store at 64-68 Castlereagh Street for $56 million.

Meanwhile in Perth, German asset manager Union Investment is in due diligence to buy an A-grade office tower from health fund HBF Health for $115 million.

Get a weekly roundup of the latest news from Commercial Real Estate, delivered straight to your inbox!

By signing up, you agree to Domain’s Privacy Policy and Conditions of Use. You may opt out at any time.